Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 308
Huang, J, Osthushenrich, T, MacNamara, A, Mälarstig, A, Brocchetti, S, Bradberry, S, Scarabottolo, L, Ferrada, E, Sosnin, S, Digles, D, Superti-Furga, G & Ecker, GF 2024, 'ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction', Rsc advances, vol. 14, no. 19, 00748, pp. 13083-13094. https://doi.org/10.1039/d4ra00748d

Activities

Leveraging integrated life science data – the power of workflows

Gerhard Ecker
255th ACS National Meeting and Exhibition
Conference, Talk or oral contribution
19.3.2018 - 19.3.2018

Triangulation of repurposing candidates for orphan diseases

Jana Gurinova , Gerhard Ecker , Daniela Digles
Nicht angegeben
Other, Poster presentation
19.3.2018 - 19.3.2018

In silico Toxicology - from prediction of transporter interaction profiles to toxicological read across and beyond

Gerhard Ecker
Frontiers in Medicinal Chemistry
Conference, Talk or oral contribution
13.3.2018 - 13.3.2018

Linking open data - from transporter interaction profiles to toxicity prediction

Gerhard Ecker
In Silico IVIVE
Seminar/Workshop, Talk or oral contribution
20.9.2017 - 20.9.2017

Predicting drug residence time - its all about how long you stay

Gerhard Ecker
Vienna Summer School on Drug Design 2017
Summer/Winter school, Talk or oral contribution
18.9.2017 - 18.9.2017